GAIN THERAPEUTICS, INC Weighted Average Number of Shares Outstanding, Basic and Diluted
GAIN THERAPEUTICS, INC (GANX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 4.87 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-10
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 4.87M shares, a 145.69% increase year-over-year.
- GAIN THERAPEUTICS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 1.98M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month |
|---|---|
| 2021-03-31 | 4.87M shares 10-Q · filed 2021-05-10 |
| 2020-03-31 | 1.98M shares 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |